Advances in Molecular Biotechnology (AMB) is a peer-reviewed scholarly journal dedicated to publishing original research that applies molecular biology to both basic and applied biotechnology. It covers a wide range of topics, including gene cloning systems, next-generation sequencing, nanobiotechnology, cell and tissue culture, disease models, synthetic biology, metabolic engineering, bioenergy, and medical biotechnology. AMB publishes high-quality scientific articles that provide comprehensive perspectives on advancements in the field. The journal employs a two-way anonymous peer review model to maintain rigorous editorial standards and facilitate the dissemination of impactful research. It serves a diverse audience of biologists, engineers, chemists, pharmacologists, computer scientists, and physicians across academic, clinical, industrial, NGO, and governmental settings. To enhance accessibility, articles are written in an easy-to-read format, encouraging authors to consider readers' varying familiarity with specific terminology.
AMB aims to be a vital resource for researchers, practitioners, and academics in biotechnology, fostering collaboration within the scientific community. It welcomes submissions that bring novel ideas and push the scientific frontier, primarily publishing Research Articles and Reviews with interdisciplinary scope and broad appeal.